Interleukin-38 Interacts with Destrin/actin-depolymerizing Factor in Human Keratinocytes
Overview
Authors
Affiliations
Interleukin (IL)-38 is a member of the IL-1 family of cytokines, which was proposed to exert anti-inflammatory effects. IL-38 is constitutively expressed in the skin, where keratinocytes are the main producing cells. Little information is currently available concerning IL-38 biology. Here, we investigated the subcellular localization and interaction partners of the IL-38 protein in human keratinocytes. IL-38 expression was reduced in primary keratinocytes grown in monolayer (2D) cultures. We thus used IL-38 overexpressing immortalized normal human keratinocytes (NHK/38) to study this cytokine in cell monolayers. In parallel, differentiation of primary human keratinocytes in an in vitro reconstructed human epidermis (RHE) 3D model allowed us to restore endogenous IL-38 expression. In NHK/38 cells and in RHE, IL-38 was mainly cell-associated, rather than released into culture supernatants. Intracellular IL-38 was preferentially, although not exclusively, cytoplasmic. Similarly, in normal human skin sections, IL-38 was predominantly cytoplasmic in the epidermis and essentially excluded from keratinocyte nuclei. A yeast two-hybrid screen identified destrin/actin-depolymerizing factor (DSTN) as a potential IL-38-interacting molecule. Co-immunoprecipitation and proximity ligation assay confirmed this interaction. We further observed partial co-localization of IL-38 and DSTN in NHK/38 cells. Endogenous IL-38 and DSTN were also co-expressed in all epidermal layers in RHE and in normal human skin. Finally, IL-38 partially co-localized with F-actin in NHK/38 cells, in particular along the cortical actin network and in filopodia. In conclusion, IL-38 is found predominantly in the cytoplasm of human keratinocytes, where it interacts with DSTN. The functional relevance of this interaction remains to be investigated.
Diaz-Barreiro A, Talabot-Ayer D, Huard A, Cereghetti G, Tonacini J, Maillasson M Cell Commun Signal. 2025; 23(1):34.
PMID: 39833821 PMC: 11744908. DOI: 10.1186/s12964-025-02035-z.
Milara J, Ribera P, Marin S, Montero P, Roger I, Cortijo J Mol Med. 2024; 30(1):134.
PMID: 39223490 PMC: 11370283. DOI: 10.1186/s10020-024-00906-8.
Huard A, Rodriguez E, Talabot-Ayer D, Weigert A, Palmer G Front Immunol. 2024; 15:1387921.
PMID: 39119344 PMC: 11306934. DOI: 10.3389/fimmu.2024.1387921.
Emerging functions and therapeutic targets of IL-38 in central nervous system diseases.
Gao Y, Cai L, Wu Y, Jiang M, Zhang Y, Ren W CNS Neurosci Ther. 2024; 30(2):e14550.
PMID: 38334236 PMC: 10853902. DOI: 10.1111/cns.14550.
Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production.
Huard A, Wilmes C, Kiprina A, Netzer C, Palmer G, Brune B Int J Mol Sci. 2023; 24(6).
PMID: 36982750 PMC: 10053218. DOI: 10.3390/ijms24065676.